Lyell ImmunopharmaLYEL
那斯達克 · USD
35.11
+0.02
(+0.06%)
盤中 12/29 11:14 (UTC+8)
12/29 11:14 (UTC+8)
Lyell ImmunopharmaLYEL
35.11
+0.02
(+0.06%)
財務數據
損益表
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- 0.00
- -58.46
- -7.41
- -48.00
- -76.92
- 333.33
- 161.54
- -67.65
- -36.36
- 14.29
- 87.50
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 15 | 8 | 7 | 11 | 34 | 13 | 3 | 13 | 25 | 27 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 15 | 8 | 7 | 11 | 34 | 13 | 3 | 13 | 25 | 27 |
營業費用 | 37,268 | 47,148 | 57,374 | 201,158 | 50,539 | 51,541 | 55,578 | 59,521 | 59,064 | 65,932 |
研發費用 | 28,172 | 34,857 | 43,447 | 48,668 | 39,500 | 40,261 | 43,174 | 46,995 | 43,849 | 47,471 |
推銷及管理費用 | 9,096 | 10,848 | 13,927 | 14,009 | 11,039 | 11,280 | 12,404 | 12,526 | 15,215 | 18,461 |
非經常性項目費用 | - | 1,443 | - | 138,481 | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -37,253 | -47,140 | -57,367 | -201,147 | -50,505 | -51,528 | -55,575 | -59,508 | -59,039 | -65,905 |
其他收入及費用 | -1,593 | 4,456 | 5,172 | 9,212 | 5,922 | 5,719 | -5,092 | 6,578 | 8,186 | 2,015 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -38,846 | -42,684 | -52,195 | -191,935 | -44,583 | -45,809 | -60,667 | -52,930 | -50,853 | -63,890 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -38,846 | -42,684 | -52,195 | -191,935 | -44,583 | -45,809 | -60,667 | -52,930 | -50,853 | -63,890 |
基本每股稅後盈餘(元) | -2.13 | -2.89 | -0.18 | -0.65 | -0.17 | -0.18 | -0.24 | - | -0.20 | -0.26 |
稀釋每股稅後盈餘(元) | -2.13 | -2.89 | -0.18 | -0.72 | -0.17 | -0.18 | -0.24 | -0.20 | -0.21 | -0.25 |
基本平均股數(千股) | 18268.00 | 14793.00 | 295098.00 | 294875.00 | 256300.00 | 255400.00 | 254252.00 | - | 251318.00 | 250204.00 |
稀釋平均股數(千股) | 18268.00 | 14793.00 | 295098.00 | 294875.00 | 256300.00 | 255400.00 | 254252.00 | - | 251318.00 | 250204.00 |
還原基本每股稅後盈餘(元) | -2.13 | -2.89 | -3.60 | -13.02 | -3.48 | -3.59 | -4.80 | - | -4.00 | -5.20 |
還原稀釋每股稅後盈餘(元) | -2.13 | -2.89 | -3.60 | -14.40 | -3.40 | -3.60 | -4.80 | -4.00 | -4.20 | -5.00 |
還原基本平均股數(千股) | 18,268 | 14,793 | 14,754 | 14,743 | 12,815 | 12,770 | 12,712 | - | 12,565 | 12,510 |
還原稀釋平均股數(千股) | 18,268 | 14,793 | 14,754 | 14,743 | 12,815 | 12,770 | 12,712 | - | 12,565 | 12,510 |
EBITDA(千元) | -37,289 | -40,714 | -50,479 | -189,874 | -43,490 | -44,670 | -60,010 | -51,257 | -48,036 | -60,903 |